Bimekizumab Improves Spinal Pain, Fatigue, Morning Stiffness in axSpA

At 16 weeks, patients treated with bimekizumab reported greater improvements in both mean spine pain and morning stiffness when compared with placebo. These improvements continued through week 52.

Related Keywords

San Diego ,California ,United States ,Philip Mease ,American College Of Rheumatology Convergence Philip Mease ,Swedish Medical Center ,University Of Washington School Medicine ,American College Of Rheumatology ,Rheumatology Research ,American College ,Rheumatology Convergence ,Treatment Improved Key Patient Reported Symptoms ,Axial Spondyloarthritis Including Spinal Pain ,Morning Stiffness ,Week Results ,Two Phase ,Washington School ,Functional Assessment ,Chronic Illness Therapy ,